CU Anschutz Department of Pharmacology
@cupharmacology.bsky.social did:plc:yxuvo4hieifcpprffxyxvvfx
Our mission is to advance the field of pharmacology through innovative and impactful research and by training the next generation of scientists at the University of Colorado Anschutz Medical Campus. https://linktr.ee/cupharmacology
No Bluesky desde
- Seguidores
- 135
- Seguindo
- 58
- Posts
- 155
- Dias nos rankings
- 0
Resumo
CU Anschutz Department of Pharmacology (@cupharmacology.bsky.social) é um usuário do Bluesky desde 21 novembro 2024. Tem 135 seguidores, segue 58 contas e publicou 155 posts.
Aparições nos rankings
Os melhores dias em que posts desta conta entraram na lista diária do Debya.
Esta conta ainda não apareceu em um ranking diário.
Posts curtidos recentemente
Curtidas públicas da rede Bluesky.
Thomas Flaig (@tomflaigmd.bsky.social), MD, Vice Chancellor for Research at CU Anschutz, continues to lead global bladder cancer treatment guidelines through his role at NCCN. At the NCCN Annual Conference, he outlined new therapies, research, and practical insights to improve patient care. (1/6)
Ver postKudos to four CCTSI program leaders recognized for excellence in #research, #mentorship, and leadership at @cuanschutz.bsky.social and nationally. We’re proud to work with Drs. Natalie Nokoff, Natalie Serkova, Janine Higgins & Paul MacLean. Congrats! 👏 @kmess44.bsky.social, @CCOS-CTSA.bsky.social
Ver postDendritic arbors provide neuroscience with an ideal opportunity to study how individual neurons interact with their broader circuitry and are the field’s best bet to bridge cellular and systems neuroscience, writes @justinkohare.bsky.social. #neuroskyence www.thetransmitter.org/dendrites/de...
Ver postEndocrine Research Conference: Dr Michael Oliphant presented really cool work on understanding breast cancer development and treatment. @cupharmacology.bsky.social
Ver postConteúdo indisponível
Ver post
Contas que bloqueia
No Bluesky, bloqueios são registros públicos.
Esta conta não bloqueia ninguém.